The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 16, 2025
Filed:
May. 15, 2020
Applicant:
Qilu Pharmaceutical Co., Ltd., Shandong, CN;
Inventors:
Yingying Yang, Jinan, CN;
Gao Li, Shandong, CN;
Yaning Wang, Shandong, CN;
Zhenming An, Shandong, CN;
Shuyong Zhao, Shandong, CN;
Yuxue Liu, Shandong, CN;
Shicong Liu, Shandong, CN;
Meijuan Zhang, Shandong, CN;
Jinjin Jiang, Shandong, CN;
Assignee:
QILU PHARMACEUTICAL CO., LTD., Shandong, CN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 31/136 (2006.01); A61K 31/282 (2006.01); A61K 31/513 (2006.01); A61K 31/69 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C07K 14/725 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 31/136 (2013.01); A61K 31/282 (2013.01); A61K 31/513 (2013.01); A61K 31/69 (2013.01); A61K 38/2026 (2013.01); A61K 38/2066 (2013.01); A61K 38/2086 (2013.01); A61K 39/0011 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/6849 (2017.08); A61K 47/6889 (2017.08); A61P 35/00 (2018.01); C07K 14/7051 (2013.01); G01N 33/57492 (2013.01); A61K 2039/572 (2013.01); A61K 2039/80 (2018.08); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/52 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/569 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01);
Abstract
Provided are an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, a derivative comprising said antibody or antigen-binding fragment thereof, a pharmaceutical composition, and related use of said antibody or antigen-binding fragment thereof for treating, diagnosing and detecting cancers.